Constipation is one of the most commonly reported side effects of semaglutide — and one of the least openly discussed. Most people starting Ozempic® or Wegovy® hear about nausea. Fewer are prepared for what can happen on the other end.
This is not a sign that the medication isn't working, and it is not a dietary mistake. Constipation on semaglutide is a predictable physiological consequence of how the medication acts on the digestive system. It is manageable, and understanding why it happens is the first step to managing it effectively.
This guide covers why semaglutide causes constipation, what the data says about how common it is and how long it typically lasts, the most effective relief strategies, and what the natural alternatives look like for readers who want appetite control without the gastrointestinal (GI) trade-offs. For more on semaglutide constipation and how GI side effects relate to the decision to stop, our guide to what happens when you stop injectable medications covers the full picture.
Why Does Semaglutide Cause Constipation?
Semaglutide activates GLP-1 (glucagon-like peptide-1) receptors distributed throughout the GI tract, significantly slowing gastric emptying and small intestine transit time. Slower transit means food and waste spend more time in the colon, where water is progressively absorbed — producing harder, drier stools.1
There is a compounding factor. Semaglutide's appetite suppression reduces overall food and fluid intake. People eat less, drink less, consume less fiber, and generate less gut motility stimuli. All of these inputs normally keep the digestive system moving. When they decrease simultaneously, the effect on transit is amplified.
That slowing is also why constipation on semaglutide catches so many people off guard — it is a direct consequence of how the medication works, not a sign that something has gone wrong.
How Common Is Constipation on Semaglutide?
Constipation affects a significantly different proportion of people depending on which semaglutide formulation they are taking and at what dose. Most competitor articles conflate these figures — the distinction matters if you are trying to understand what to expect.
Constipation Rates by Formulation and Dose
| Formulation | Dose / Indication | Constipation Incidence (%) |
|---|---|---|
| Ozempic® (injection)2 | 0.5 mg / Type 2 diabetes | 5% |
| Wegovy (injection)3 | 2.4 mg / weight management | 24% |
| Rybelsus® (oral)4 | 7 mg / Type 2 diabetes | 6% |
| Wegovy (oral)5 | 25 mg / weight management | 20% |
| Zepbound (injection)6 | 10 mg / weight management | 14% |
The dose is the primary driver of incidence. People on Wegovy 2.4 mg for weight management face a substantially higher rate than those on lower Ozempic doses for Type 2 diabetes.7,8
Also important: constipation from semaglutide tends to persist longer than nausea and is often less discussed, despite being just as disruptive over weeks of treatment. In fact, in the pivotal 68-week semaglutide studies, the median duration constipation varied between 42 and 47 days, although around 7-10% of participants experienced it for the entire time.9
A Counterintuitive Finding Worth Knowing
A May 2026 retrospective analysis presented at Digestive Disease Week by Thomas Fredrick, MD., of the Mayo Clinic, found that participants on semaglutide who experienced constipation had 14.4% total body weight loss at 12 months, compared to 10.8% in those without constipation.10
Constipation was associated with higher doses and lower rates of Type 2 diabetes — the population most likely reading this article.
This finding should be interpreted carefully. As Fredrick himself acknowledged, it is hypothesis-generating, not established causation. It does not mean constipation is desirable. What it may offer a reader who feels like something is going wrong is a reframe: constipation at higher semaglutide doses may be a signal that the medication is working at the level that produces results.
It's also important to note that the STEP trials of semaglutide in weight management showed no differences in weight loss between those who experienced GI side effects (which amounted to a quarter of the semaglutide group).11
How Long Does Semaglutide Constipation Last?
For people on Wegovy 2.4 mg, the median duration of constipation was 47 days, compared to 35 days in the placebo group, with prevalence plateauing at approximately week 10.12 That plateau is meaningful: for most people, constipation does not continue to worsen indefinitely as the drug accumulates.
Many people resolve symptoms within 2 to 3 weeks once dietary adjustments are made and the body adapts to the initial titration phase. Constipation tends to peak during dose escalation; each new dose increment is when symptoms are most likely to worsen or return.
For up to 10% of people, constipation persists throughout treatment at the higher maintenance dose.13 This is where sustained dietary and lifestyle management, and where necessary, ongoing OTC support, becomes part of the long-term routine.
The Best Relief Strategies for Semaglutide Constipation
Most cases respond well to a combination of dietary, lifestyle, and, where necessary, pharmacological interventions. The goal is to work with the medication, not against it.
Hydration
Semaglutide's appetite suppression often reduces unconscious fluid intake; people drink less because they eat less and feel less thirsty. What's more, these medication types also act centrally in the brain to reduce thirst.14 Try to keep up your water intake, regardless, though avoid drinking excessively during meals and don't use a straw to drink.15
A practical tip: a large glass of water first thing in the morning, before food, stimulates the "gastrocolic reflex" and can prompt a bowel movement. Electrolyte drinks — coconut water, oral rehydration solutions — can help if nausea is making plain water unappealing. (Note that if you're taking the Wegovy pill, you need to wait at least 30 minutes from taking it before you drink a large glass of water.)
Fiber — Gradual Increases, Not Sudden Ones
It's very important to maintain adequate dietary fiber if you're constipated (but to limit it if you're experiencing diarrhea).16 However, increasing fiber too quickly when already constipated can worsen bloating and discomfort, so aim to gradually up your daily fiber intake. Soluble fiber is particularly effective — oats, legumes, chia seeds, and psyllium husk absorb water, soften stool, and feed gut bacteria that support motility. If eating significantly less on semaglutide, prioritize fiber-dense foods at every meal: vegetables, legumes, and fruit with skin. For a guide on fiber-rich foods, see this Mayo Clinic chart.
Movement
Physical activity stimulates intestinal contractions and speeds gut transit time — one of the most clinically supported non-pharmacological interventions for constipation.17 Twenty to thirty minutes of daily walking has a meaningful impact on gut motility; consistency matters more than intensity.
Meal Structure
Eating regular meals at consistent times supports the body's natural motility rhythms. Irregular eating or skipping meals due to low appetite disrupts this. Warm liquids in the morning — water, herbal tea — help stimulate gut motility. Small, structured meals are better for gut function than prolonged fasting during the day, even when appetite is very low.18
Over-the-Counter Options
If dietary and lifestyle adjustments do not resolve constipation within 1 to 2 weeks, OTC options are appropriate:
- Osmotic laxatives (polyethylene glycol 3350 /MiraLax®): recommended by gastroenterologists for semaglutide-related constipation, they draw water into the colon to soften stool; gentle, non-habit-forming; safe for extended use.19
- Stool softeners (docusate sodium): may be useful for mild constipation, although docusate is widely used as a laxative, its clinical effectiveness remains unproven and it's not FDA-approved for the treatment of constipation.20 Users may become dependent on docusate.
- Stimulant laxatives (senna, bisacodyl): senna has better evidence in support of its use for (general) chronic constipation than bisacodyl, but neither has been specifically recommended for treating GLP-1 constipation.21 Stimulant laxatives should be reserved for short-term or rescue use only.
- Psyllium husk: a soluble fiber supplement that works as a gentle osmotic agent; it requires adequate hydration to work safely. Psyllium is the most effective fiber supplement for treating chronic constipation.22
Always consult a prescribing doctor before adding regular OTC laxatives alongside semaglutide, particularly for those managing Type 2 diabetes.
Natural GLP-1 Support Without the Digestive Side Effects
GI side effects are among the leading reasons people discontinue GLP-1 medications, and constipation, while likely less distressing than nausea or vomiting, accumulates as a quality-of-life issue over weeks and months.
The mechanism that causes constipation is inseparable from pharmaceutical-strength GLP-1 receptor activation. Flooding GLP-1 receptors throughout the body slows gastric emptying along the entire GI tract. The GI disruption is not a flaw in the design — it is the design, operating at pharmacological doses.
Natural GLP-1 stimulation works differently. Increasing your body's levels of its natural GLP-1 can help manage your appetite without the body-wide receptor activation that drives GIslowdown at pharmacological doses. The appetite signal is real. The mechanism is different.
Amarasate, the active ingredient in Calocurb®, does exactly this, by stimulating bitter taste receptors on specialized "enteroendocrine L-cells" throughout the gut, which then triggers local release of the body's own GLP-1 (and other "stop eating" hormones, CCK and PYY). Three peer-reviewed, published human clinical trials show:
~18%
Reduction in caloric intake at a subsequent meal, with measurable increases in GLP-1 and other satiety hormones (640% for GLP-1, 600% for CCK, and 170% for PYY over baseline)23
Significant
Hunger reduction in men during a 24-hour fast24
30%
Hunger reduction, 40% reduction in food cravings, and 14% fewer calories consumed in women during a 24-hour fast25
No statistically significant adverse effects were reported across the three trials. Effects on appetite were measurable within one hour of dosing. Amarasate is not a replacement for people who clinically need pharmaceutical GLP-1 management. It is the evidence-backed option for people who want appetite control without the GI trade-offs — or who are transitioning off semaglutide and want to maintain results. It's also been used alongside GLP-1s to allow for a reduced dose of the medication and a reduction in their side effects. For more on why appetite support matters post-GLP-1, our guide covers the transition in detail.
Learn more at Calocurb's science page or explore the product.
Natural appetite control
Support appetite without the GI side effects
Calocurb® activates your body's natural GLP-1 without slowing gastric emptying. Three peer-reviewed clinical trials show meaningful appetite reduction and satiety hormone increases — with no statistically significant adverse effects.
